1-5 of 5
Tania J. Curcio, R.N.
Close
Sort by
Journal Articles

First-in Man, Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients with CD123+ Acute Myeloid Leukemia (AML) in CR at High Risk for Early Relapse

B. Douglas Smith, MD, Gail J. Roboz, MD, Roland B. Walter, MD PhD, Jessica K. Altman, MD, Anna Ferguson, BSN, RN, Tania J. Curcio, R.N, Kaysey F. Orlowski, Linda Garrett, RN, Samantha J Busfield, PhD, Megan Barnden, PhD, Brad Sedgmen, PhD, Souravi Ghosh, PhD, Sarah Hosback, PhD, Roslyn Davis, MSc, Allison Dyson, BSc, Sue Dasen, MS, Mark DeWitte, VMD, Debra M. Bensen-Kennedy, MD, Andrew W. Roberts, MBBS, PhD
Journal: Blood
Blood (2014) 124 (21): 120.
https://doi.org/10.1182/blood.V124.21.120.120
Published: 2014
Journal Articles

Comprehensive Geriatric Assessment Does Not Predict Overall Survival in Older Patients with Acute Myeloid Leukemia (AML)

Ellen K. Ritchie, MD, Danielle C. Marshall, B.A., Molly D. Greenberg, B.S., Tania J. Curcio, R.N, Ashley E. Giambrone, PhD, Paul Christos, DrPH, Eric J. Feldman, MD, Joseph M. Scandura, MD PhD, Gail J. Roboz, MD
Journal: Blood
Blood (2014) 124 (21): 3689.
https://doi.org/10.1182/blood.V124.21.3689.3689
Published: 2014
Journal Articles

A Novel Sequential Treatment Utilizing CPX-351 As Salvage Chemotherapy Followed by a Reduced Intensity Conditioning Allogeneic Stem-Cell Transplantation for Patients with Refractory Leukemia

Usama Gergis, MD, Gail J. Roboz, MD, Ellen Ritchie, MD, Joseph M. Scandura, MD, PhD, Karen-Sue B. Carlson, MD, PhD, Tsiporah B. Shore, MD, Sebastian Mayer, MD, Tomer M Mark, MD, MSc, Roger N Pearse, MD, PhD, June Greenberg, Tania J Curcio, R.N, Cindy Ippoliti, PharmD, Marshall McKenna, Eric J Feldman, MD
Journal: Blood
Blood (2011) 118 (21): 3030.
https://doi.org/10.1182/blood.V118.21.3030.3030
Published: 2011
Journal Articles

Arsenic Trioxide (ATO) Is Safe and Effective in Combination with Low-Dose Ara-C (LDAC) for the Treatment of IPSS-2 Myelodysplastic Syndrome (MDS) and Poor-Prognosis Acute Myeloid Leukemia (AML) in Elderly Patients.

Gail J. Roboz, MD, Ellen K. Ritchie, MD, Sandra Allen-Bard, N.P., Tania J. Curcio, R.N., Juliette L. Provenzano, MS, Michael S. Samuel, BA, Michael W. Schuster, MD, Alison W. Bloch, BA, Eric J. Feldman, MD
Journal: Blood
Blood (2005) 106 (11): 2805.
https://doi.org/10.1182/blood.V106.11.2805.2805
Published: 2005
Journal Articles

Gemtuzumab Ozogamicin Is an Acceptable Alternative to Anthracyclines in Combination with Standard Dose Infusional Cytarabine as Induction Therapy for Elderly Patients with Acute Myeloid Leukemia (AML).

Gail J. Roboz, MD, Ellen K. Ritchie, MD, Michael W. Schuster, MD, Tsiporah Shore, MD, Tania J. Curcio, R.N., Sandra Allen-Bard, N.P., Juliette L. Provenzano, MS, Eric J. Feldman, MD
Journal: Blood
Blood (2005) 106 (11): 1856.
https://doi.org/10.1182/blood.V106.11.1856.1856
Published: 2005